stars 1 stars 2 stars 3

Together with our strategic partner, Academia Sinica in Taiwan, we strive for continuous innovation on glycan-based technology and are committed to deliver best-in-class targeted and differentiated products. Our goal is to bring advanced, high-quality and affordable medicines, diagnostics and therapies to patients around the world. Fulfill our vision through sharing, co-creation and pursuing excellence. CHO Pharma is dedicated to address unmet medical needs and to deliver solutions valuable to patients through its innovative glycan engineering technologies and platforms, and brand Taiwan biotechnology in the global arena. As a research-oriented company committed to innovation, CHO Pharma's missions are to become a global leading biopharmaceutical company specialized on glycan-based technology, to keep sustainable growth and develop products that are beneficial to patients worldwide. ABOUT USPRODUCTSNEWSCAREERSCONTACT USHOME

CHO Pharma Questions

The CHO Pharma annual revenue was $5.5 million in 2026.

1 people are employed at CHO Pharma.

CHO Pharma is based in Taipei, Taipei.

The NAICS codes for CHO Pharma are [3254, 32, 32541, 325].

The SIC codes for CHO Pharma are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users